© 2002 Journal of Medical Genetics
LETTER TO JMG
Mosaicism for FMR1 and FMR2 deletion: a new case
Institute of Human Genetics, Johann Wolfgang Goethe University Hospital, Theodor-Stern-Kai 7, D-60590 Frankfurt/Main, Germany
Correspondence to:
Correspondence to:
Dr J Arnemann, Institute of Human Genetics, Johann Wolfgang Goethe University Hospital, Theodor-Stern-Kai 7, D-60590 Frankfurt/Main, Germany;
Arnemann@em.uni-frankfurt.de
Keywords: FMR1; FMR2; mosaicism; fragile X syndrome
Fragile X syndrome is the most common disorder causing mental retardation with an estimated prevalence of between 1 in 4000 to 1 in 6000 males.1, 2 In nearly all cases, the molecular basis of this X linked mental impairment is an amplification in excess of 200 copies of an unstable CGG trinucleotide repeat sequence within the 5` untranslated region of the FMR1 gene (FRAXA, MIM 309550) at Xq27.3.3 This causes an inhibition of the transcription leading to a loss of function effect in the male. In the female, the amplified gene is preferentially X inactivated by methylation.4 However, the X inactivation pattern can vary between different cell types and during development and thus, usually, causes a milder phenotype in female patients.5 In close distal proximity to the FMR1 gene, a second gene, FMR2 (FRAXE, MIM 309548) involved in mental retardation, has been described with amplification of an unstable GCC trinucleotide repeat
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
